2014
DOI: 10.1080/01635581.2014.956248
|View full text |Cite
|
Sign up to set email alerts
|

Postoperative Hypocaloric Peripheral Parenteral Nutrition With Branched-Chain-Enriched Amino Acids Provides No Better Clinical Advantage Than Fluid Management in Nonmalnourished Colorectal Cancer Patients

Abstract: To assess clinical efficacy of using postoperative branched-chain amino acids (BCAAs)-enriched nutritional support in lower gastrointestinal cancer patients, we conducted a retrospective observational study comparing this regimen with traditional fluid management. Sixty-one eligible colorectal cancer patients consecutively admitted in the Colorectal Surgery Ward to receive postoperative hypocaloric peripheral parenteral nutrition (HPPN) were categorized into dextrose-only control group (n = 20), dextrose plus … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2017
2017
2021
2021

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 31 publications
0
2
0
Order By: Relevance
“…A total of 276 studies were included in the larger project, with 20 relevant BCAAs articles included here reporting on 19 studies. These comprised 13 RCTs 53 -65 and 6 observational cohort studies in 7 reports 66 -72 on BCAAs, and included 2019 total participants overall across the studies.…”
Section: Resultsmentioning
confidence: 99%
“…A total of 276 studies were included in the larger project, with 20 relevant BCAAs articles included here reporting on 19 studies. These comprised 13 RCTs 53 -65 and 6 observational cohort studies in 7 reports 66 -72 on BCAAs, and included 2019 total participants overall across the studies.…”
Section: Resultsmentioning
confidence: 99%
“…Existing literature shows that the experience of using peripheral PN is more extensive in patients with gastrointestinal tract cancer undergoing surgery than other disease states 3 . ‐ 5 One recent retrospective observational trial of peripheral PN in postoperative colorectal cancer patients showed no clinical advantage with peripheral PN administration 6 . However, the study excluded malnourished subjects and focused on supplementation with branched‐chain amino acids, limiting any applicability of the findings.…”
Section: Question 6: In Which Patients Is Peripheral Pn a Reasonable mentioning
confidence: 99%